CORY RATHGEBER: Open Payments
NPI 1649367343 · DICKINSON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 58 payments from 15 companies in 2025. Trend: 2023 $969 · 2024 $1,307 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $180 |
| PFIZER INC. | 13 | $168 |
| ABBVIE INC. | 13 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $22 |
| Verona Pharma, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, NURTEC ODT, EVENITY, TRINTELLIX, CAPLYTA, OTEZLA, ELIQUIS, INGREZZA.
Industry payments across ND — which companies pay providers there.
